Generation and characterization of a monoclonal antibody that recognizes an activation antigen expressed by a majority of adherent lymphokine-activated killer cells

被引:2
|
作者
Chan, CS [1 ]
Kane, KP [1 ]
机构
[1] Univ Alberta, Dept Med Microbiol & Immunol, Fac Med, Edmonton, AB T6G 2S2, Canada
来源
HYBRIDOMA | 2000年 / 19卷 / 01期
关键词
D O I
10.1089/027245700315798
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
In an attempt to generate murine natural killer (NK) cell-specific monoclonal antibodies (MAbs) by immunizing Balb/c mice with C57BL/6 (B6) A-LAKs, we have isolated a hybridoma, CS/NicT.2, which secretes an IgM that recognizes a majority of B6 and B6 Rag-1(-/-) A-LAKs. The CS/NicT.2 antigen is highly expressed by A-LAKs, but only at extremely low levels on resting splenocytes, suggesting that its expression is tightly associated with IL-2 activation, Among the cell lines examined, only CTLL-2 expresses the CS/NicT.2 antigen at relatively high levels. A low level of CS/NicT.2 staining is also detected on resting allo-specific cytotoxic T lymphocytes (CTL) clones, AB.1 and C11. In addition, a similar low level of CS/NicT.2 staining is detected on the T-helper cell line HT-2, The CS/NicT.2 antigen is upregulated by ionomycin but not by phorbol 12-myristate 13-acetate (PMA). For the CTL clones examined, CS/NicT.2 staining is also dramatically increased by anti-TCRbeta or anti-CD3(epsilon) stimulation, Protease treatments of CTLL-2 show that this antigen is proteinase K sensitive, but relatively resistant to trypsin digestion. Furthermore, the CS/NicT.2 antigen exhibits a relatively fast turnover rate as assessed by proteinase K and cycloheximide treatments of CTLL-2, suggesting that the CS/NicT.2 antigen may have a short half-life on the cell surface.
引用
收藏
页码:49 / 61
页数:13
相关论文
共 50 条
  • [31] GENERATION OF LYMPHOKINE-ACTIVATED KILLER-CELLS DOES NOT REQUIRE DNA-SYNTHESIS
    MALKOVSKY, M
    JIRA, M
    MADAR, J
    MALKOVSKA, V
    LOVELAND, B
    ASHERSON, GL
    IMMUNOLOGY, 1987, 60 (03) : 471 - 473
  • [32] THE GENERATION OF HUMAN LYMPHOKINE-ACTIVATED KILLER (LAK) CELLS USING INTERLEUKIN-4
    JADUS, MR
    GOOD, RW
    CRUMPACKER, DB
    YANNELLI, JR
    JOURNAL OF BIOLOGICAL RESPONSE MODIFIERS, 1989, 8 (03): : 329 - 329
  • [33] GENERATION OF LYMPHOKINE-ACTIVATED KILLER ACTIVITY IN T-CELLS - POSSIBLE REGULATORY CIRCUITS
    GELLER, RL
    SMYTH, MJ
    STROBL, SL
    BACH, FH
    RUSCETTI, FW
    LONGO, DL
    OCHOA, AC
    JOURNAL OF IMMUNOLOGY, 1991, 146 (10): : 3280 - 3288
  • [34] INFLUENCE OF IMMUNIZATION OF MICE INVIVO ON THE GENERATION INVITRO OF LYMPHOKINE-ACTIVATED KILLER (LAK) CELLS
    VANHAESEBROECK, B
    GROOTEN, J
    FIERS, W
    ARCHIVES INTERNATIONALES DE PHYSIOLOGIE DE BIOCHIMIE ET DE BIOPHYSIQUE, 1987, 95 (05): : B246 - B246
  • [35] STUDIES OF SERUM-FREE MEDIUM FOR THE GENERATION OF LYMPHOKINE-ACTIVATED KILLER-CELLS
    TOGAMI, M
    YASUMOTO, K
    YANO, T
    ISHIDA, T
    KIMURA, G
    SUGIMACHI, K
    NOMOTO, K
    CYTOTECHNOLOGY, 1991, 6 (01) : 39 - 47
  • [36] LYMPHOKINE-ACTIVATED KILLER CELL PHENOMENON .3. EVIDENCE THAT IL-2 IS SUFFICIENT FOR DIRECT ACTIVATION OF PERIPHERAL-BLOOD LYMPHOCYTES INTO LYMPHOKINE-ACTIVATED KILLER CELLS
    GRIMM, EA
    ROBB, RJ
    ROTH, JA
    NECKERS, LM
    LACHMAN, LB
    WILSON, DJ
    ROSENBERG, SA
    JOURNAL OF EXPERIMENTAL MEDICINE, 1983, 158 (04): : 1356 - 1361
  • [37] HUMAN LYMPHOKINE-ACTIVATED KILLER CELLS - FURTHER ISOLATION AND CHARACTERIZATION OF THE PRECURSOR AND EFFECTOR CELL
    SKIBBER, JM
    LOTZE, MT
    MUUL, LM
    UPPENKAMP, IK
    ROSS, W
    ROSENBERG, SA
    NATURAL IMMUNITY AND CELL GROWTH REGULATION, 1987, 6 (06) : 291 - 305
  • [38] AUTOCYTOTOXIC ACTIVITY OF LYMPHOKINE-ACTIVATED KILLER CELLS - CHARACTERIZATION OF EFFECTOR-CELLS AND SUSCEPTIBLE TARGETS
    SUZUKI, H
    IKEMOTO, M
    KAMITANI, T
    HOSHINO, K
    YANO, S
    ANTICANCER RESEARCH, 1989, 9 (02) : 293 - 298
  • [39] ANTIVIRAL EFFECT OF LYMPHOKINE-ACTIVATED KILLER CELLS - CHARACTERIZATION OF EFFECTOR-CELLS MEDIATING PROPHYLAXIS
    BUKOWSKI, JF
    YANG, H
    WELSH, RM
    JOURNAL OF VIROLOGY, 1988, 62 (10) : 3642 - 3648
  • [40] LARGE-SCALE PREPARATION OF ADHERENT LYMPHOKINE-ACTIVATED KILLER (A-LAK) CELLS FOR ADOPTIVE IMMUNOTHERAPY IN MAN
    MELDER, RJ
    ROSENFELD, CS
    HERBERMAN, RB
    WHITESIDE, TL
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 1989, 29 (01) : 67 - 73